Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tecadenoson (CVT-510) 是 A1 腺苷受体的选择性激动剂。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 963 | 现货 | ||
2 mg | ¥ 1,420 | 现货 | ||
5 mg | ¥ 2,330 | 现货 | ||
10 mg | ¥ 3,760 | 现货 | ||
25 mg | ¥ 5,930 | 现货 | ||
50 mg | ¥ 8,360 | 现货 | ||
100 mg | ¥ 11,200 | 现货 | ||
500 mg | ¥ 22,500 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 2,430 | 现货 |
产品描述 | Tecadenoson (CVT-510) is a selective agonist of A1 adenosine receptor. |
体外活性 | Tecadenoson is approximately 5 fold more potent to prolong the stimulus-to-His bundle (S-H interval), a measure of slowing AV nodal conduction (EC50=41?nM) than to increase coronary conductance (EC50=200?nM) in the atrial-paced isolated heart. Tecadenoson shortens atrial (EC50=73?nM) but not the ventricular monophasic action potentials (MAP). At concentrations of Tecadenoson (40?nM) and diltiazem (1?μM) that induces equal prolongation of S-H interval (~10?ms), diltiazem, but not Tecadenoson, significantly decreases left ventricular developed pressure (LVP) and markedly increases coronary conductance [1]. |
体内活性 | Intravenous infusions of Tecadenoson and diltiazem causes nearly equal prolongations of P-R interval In atrial-paced anaesthetized guinea-pigs. Tecadenoson (2, 5, 20 μg/kg i.p.) causes a rapid and sustained dose-dependent decrease in NEFA at doses that do not cause bradycardia. Tecadenoson (50 μg/kg) treatment induces a significant bradycardia (50% decrease in heart rate at 25 min) [1][2]. |
别名 | CVT-510 |
分子量 | 337.33 |
分子式 | C14H19N5O5 |
CAS No. | 204512-90-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 155 mg/mL (459.49 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.9645 mL | 14.8223 mL | 29.6446 mL | 74.1114 mL |
5 mM | 0.5929 mL | 2.9645 mL | 5.9289 mL | 14.8223 mL | |
10 mM | 0.2964 mL | 1.4822 mL | 2.9645 mL | 7.4111 mL | |
20 mM | 0.1482 mL | 0.7411 mL | 1.4822 mL | 3.7056 mL | |
50 mM | 0.0593 mL | 0.2964 mL | 0.5929 mL | 1.4822 mL | |
100 mM | 0.0296 mL | 0.1482 mL | 0.2964 mL | 0.7411 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Tecadenoson 204512-90-3 GPCR/G Protein Neuroscience Adenosine Receptor Inhibitor CVT 510 P1 receptor CVT510 inhibit CVT-510 inhibitor